Where to Buy AOD-9604 in the UK
AOD-9604 is a specific fragment of a much larger molecule, and listings frequently describe it imprecisely. This guide covers what the documentation should state and what is available.
Independent lab testingBatch chromatogramDispatch before cut-offNo indication of contents
AOD-9604 corresponds to the C-terminal 176-191 region of human growth hormone with an added tyrosine. Almost all confusion in this market comes from that relationship.
AOD-9604 is a short synthetic fragment, not recombinant hGH. Suppliers who blur the two are either confused or trading on it. The molecular weight difference is enormous and settles the question instantly.
The same region is sold under that name without the N-terminal tyrosine modification that defines AOD-9604. They are related but not identical, and the certificate should specify which.
The fragment contains cysteine residues, so correct disulfide pairing is part of its identity. Scrambled or reduced material can pass a purity check while behaving differently.
Free cysteine and methionine both oxidise on the shelf. A recent analysis date carries real weight here, unlike on an oxidation-resistant tetrapeptide.
Research use only. Nothing on this page is medical advice, and no therapeutic claim is made or implied for any compound listed.
AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment (amino acids 176–191) of human growth hormone, studied in metabolic research models. Because it is a defined fragment rather than a full-length molecule, the Certificate of Analysis should state the fragment range explicitly. It is supplied as lyophilised powder in a sealed vial.
Classification
Synthetic growth hormone fragment
Format supplied
vial
Relationship to hGH
Synthetic analogue of the hGH(176-191) C-terminal fragment with an added tyrosine
Structural note
Contains cysteine residues; correct disulfide pairing is part of the specification
Purity specification
HPLC assay, 99% minimum, chromatogram provided on request and with the order
Research use only
Not a medicine. Not for human or veterinary consumption.
AOD-9604 is supplied as a single lyophilised vial size. Because oxidation is the limiting factor rather than time in the freezer, matching purchase to use is worthwhile.
Product
Format
Size
Price
Stock
The handling rules for AOD-9604 all trace back to the cysteines in the sequence.
Cap the vial immediately and keep bench time short. Oxidation of cysteine and methionine residues is the main degradation route and it is entirely a function of exposure.
Reconstitute in plain bacteriostatic water. Any reducing agent will break the disulfide and the resulting material is no longer the compound you bought.
Sealed powder at −20 °C for long holding; reconstituted solution refrigerated, protected from light and divided into single-use aliquots.
Same working day dispatch before the cut-off, tracked and plain-packaged, with 48-hour photographic damage cover for replacement or full refund including return postage.
For laboratory research, yes. It is not a licensed medicine, must not be marketed as one, and must not be used for human or veterinary consumption.
No. It is a short synthetic fragment based on the C-terminal 176-191 region of human growth hormone, with an added N-terminal tyrosine. Recombinant hGH is a full 191-residue protein and a completely different product.
AOD-9604 carries an N-terminal tyrosine modification that the plain fragment does not. They are close relatives, so the certificate needs to state which sequence was synthesised and analysed.
It identifies which amino acids of the parent growth hormone sequence the fragment corresponds to — residues 176 through 191. A COA that does not state the fragment range is not fully identifying what is in the vial.
No. It is a short synthetic fragment of the C-terminal region, not the full-length 191-amino-acid molecule, and it is studied for a different research profile.
Because the cysteine residues in the fragment must pair correctly for the molecule to have the structure stated. Scrambled or reduced material can still return a respectable HPLC purity figure while being structurally wrong.
Sealed at −20 °C for long-term holding, 2–8 °C short term, with minimal air exposure. Reconstitute in plain bacteriostatic water and never in a diluent containing reducing agents.
Yes, within 14 days of receipt if unopened and in original sealed packaging. Unsealed vials are excluded for health-protection reasons and your statutory rights are unaffected.
Other guides covering compounds that share a family, a use case or a failure mode with this one.